Announcement:
Contact Us
Address: Tangyin Changhong Road East
Phone: 86-372-6217645
Fax: 0372-6212598
Industry News
Call of national drug policies to support
Date:2013-05-23    Clicks:2291

Folk medicine has a strange effect, is the wisdom of minorities. However, due to national drug started late, slow development, is far behind traditional Chinese medicine. National drug innovation and development to become very real, urgent problems. How can I improve national drug advantage and expand national drug development space? How to come up with scientific data to make national drug efficacy more convincing? Research and development of the national drug where to go? Is the innovation and development of Chinese medicine in a topic worth considering.

Barriers facing the development of national drug

In chronic disease prevention and treatment, folk medicine has a unique advantage. However, so far, most of the people of the nation do not understand medicine, due to the lack of modern medicine and modern science scientific explanation clinical data, many people do not accept the national medicines. Even Qizheng Tibetan Medicine in the capital markets with impressive results, even Tibetan, Mongolian, Uygur medicine, Miao medicine and some clinical efficacy of pharmaceutical companies flagship product is very good, but after a period of product sales, it seems that the market suddenly saturated , narrow living space so that the development of national pharmaceutical companies, lack of stamina, innovation has become the nation's pharmaceutical companies lie in front of national pharmaceutical companies must cross mark.

Recently, the chairman Lei Jufang Qizheng Tibetan Medicine Science and Technology Daily reporter in an interview, stressed that the national importance of the secondary development of medicine, she thought, and traditional Chinese medicine, chemical medicine compared to national drug innovation has some difficulties. By lifestyle and cultural heritage and other factors, is not easy to grow up national pharmaceutical companies, it is difficult to give full play to its own advantages, national pharmaceutical companies should make use of high technology to transform traditional industries, to enhance the national drug product quality and the level of modernization.

"There has come to a crucial point in the development of folk medicine." Lei Jufang stressed that there must be scientific data to prove the efficacy of national drug must pass the secondary development to improve drug quality and standards, thereby enhancing the quality of medicines. Folk medicine in order to become bigger and stronger, we must "challenge exam", crossed this threshold.

Set for the secondary development of "national drug projects"

In fact, in recent years, the state attaches great importance to the secondary development of a large variety of traditional Chinese medicine. A large variety of traditional Chinese medicine has become secondary development strategy to lead the development of innovative medicine industry an important strategy in promoting the rapid development of Chinese medicine market has played a crucial role.

Secondary development of traditional Chinese medicine have had many good examples of success. For example Tasly's "CSDP" is in the "Danshen tablets" based on the secondary development after listing, the product now sells more than 10 billion yuan, sit tight in the domestic sales of proprietary single product brand. Po Chai Pills, Huxinling so on through secondary development success.

Henan Wanxi pharmaceutical medicine attaches great importance to the secondary development work, the company official told reporters that at present, Wanxi pharmaceutical enterprise products combine advantages of doing some mature products of secondary development, which is expected in the future will continue to have the old products new formulations market.

A large variety of traditional Chinese medicine led to a large number of secondary development of a large variety of traditional Chinese medicine to take off again, and promote the rapid development of Chinese medicine industry. According to incomplete statistics, at present in more than 270 Chinese large variety of over billion total sales have occupied 50 percent of the Chinese medicine market, a large variety of traditional Chinese medicine to actively promote the work of the secondary development of Chinese medicine will become the focus of scientific and technological innovation.

Slower than the development of traditional Chinese folk medicine. Chinese folk medicine has been catching up.

This year's "two sessions" period, China's national pharmaceutical leader, chairman Lei Jufang Qizheng Tibetan Medicine has recommended that traditional Chinese medicine, folk medicine in order to obtain a large development, we must strengthen the R & D and innovation, she suggested that a large variety of two in medicine times in the establishment of special national drug development projects.

Lei Jufang said: "The national drug industry, medicine industry urgently needs to draw on the successful experience of development in the country to encourage a large variety of secondary development of science and technology under the guidance of supportive policies, the more promising varieties through secondary development of bigger and stronger, promote the development of national drug industry. "

She suggested that the state in the development of Chinese science and technology sector a large variety of secondary development of national drug policies to set a special deal, the national drug has advantages, there are a large number of national medical market demand for treatment of some of the common drugs include support range, such as orthopedic chronic degenerative disease , skin diseases; Meanwhile, for restricting the development of national drug promotion after the listing of evidence-based research into drugs economics focus on supporting content, and encourage a new national drug formulation development.

Facing the development of a good time

Expert analysis, the development of national drug urgent need to determine the status of its key species for secondary development.

In Tibetan, Mongolian, Uygur medicine as the representative of our country folk medicine is an important part of traditional medicine, and has accumulated a large number of effective, safe and economical prescription. In recent years, the country to vigorously promote the development of national drug policy, folk medicine has been rapid development, many prescription medicines to be developed into, and was used to promote the national market, promote local economic development in ethnic regions, but also makes people of all nationalities can enjoy the nation's health outcomes.

However, due to the late start of national pharmaceutical development, medicinal material is weak basic research in pharmaceutical technology, clinical research, basic experimental and clinical aspects of promotion is relatively backward, causing many experienced clinically proven, effective security is superb, reasonably priced products difficult to meet the requirements of domestic pharmaceutical marketing. Many good product sales sluggish growth, enterprise development difficulties, greatly hindered the growth of the national drug industry. Therefore, the national drug industry urgently needs to learn the successful experience of the development of traditional Chinese medicine industry in the country to encourage a large variety of secondary development of science and technology under the guidance of supportive policies, the more promising varieties through secondary development of bigger and stronger, to promote national drug industry development.

"Now is a good time for the development of folk medicine." Lei Jufang say, medicine and pharmacy in the continuous development of antibiotics such drugs, its limitations have been exposed, and medicine, folk medicine, so start from the overall drug treatment, advantage is gradually reflected. Proved to select through market experience, the main varieties are clinically approved for secondary development, you can make up the potential for enterprise development, enterprise operations and development.

According to the reporter, currently Qizheng Tibetan Medicine is working with some of the best domestic research institutions to carry out nine large variety of secondary development, and strive to research and innovation in folk medicine to new highs.

Lei Jufang recommendations: a large variety of secondary development of folk medicine should be prepared to top-level design, the focus should be possible to select a national renewable raw material drug types, the market should be rational, objective analysis of national pharmaceutical companies because of limited funds, while the development of national drug should focus on ecological and environmental protection.

As national drug companies generally face weak basic research, R & D personnel missing, lack of funding difficulties, and therefore a large variety of secondary development on the road to greater need for national science and technology policy support. I hope some big national authorities in the development of science and technology policy, serious experience between Ethnic Medicine and Chinese medicine industry in the development stage and on the basis of the gap.

Copyright © 2014 河南制药有限公司 All Rights Reserved. Yu ICP:豫ICP备11016207号-1 design:In the domain of online
Address:Tangyin Changhong Road East Phone:86-372-6217645 Fax:0372-6212598 Website:www.dongtaipharm.com